John S. Cochran's most recent trade in Aquestive Therapeutics Inc was a trade of 50,500 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Mr. John S. Cochran | Director | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (Right to Purchase) | ||
| Aquestive Therapeutics Inc | Mr. John S. Cochran | Director | 11 Jun 2025 | 42,000 | 42,000 | - | - | Stock Option (Right to Purchase) | ||
| Aquestive Therapeutics Inc | Mr. John S. Cochran | Director | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | ||
| Aquestive Therapeutics Inc | Mr. John S. Cochran | Director | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | ||
| Aquestive Therapeutics Inc | Mr. John S. Cochran | Director | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) |